Description: Leap Therapeutics, Inc. is a biopharmaceutical company. It develops novel therapeutics for the treatment of cancer. Leap Therapeutics, Inc. is based in Cambridge, United States.
Home Page: www.leaptx.com
LPTX Technical Analysis
47 Thorndike Street
Cambridge,
MA
02141
United States
Phone:
617 714 0360
Officers
| Name | Title |
|---|---|
| Mr. Douglas E. Onsi J.D. | CFO, Gen. Counsel, Treasurer & Sec., Pres, CEO & Director |
| Mr. Augustine J. Lawlor | Chief Operating Officer |
| Dr. Cynthia A. Sirard | Chief Medical Officer |
| Mr. Mark O'Mahony | Chief Manufacturing Officer |
| Ms. Christine M. Granfield | VP and Head of Regulatory Affairs & Quality |
| Dr. Jason S. Baum Ph.D. | VP & Head of Translational Medicine |
| Dr. Walter Newman | Sr. Research Fellow |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.7278 |
| Price-to-Sales TTM: | 129.9425 |
| IPO Date: | 2017-01-25 |
| Fiscal Year End: | December |
| Full Time Employees: | 36 |